Nicholas Beazley‐Long

793 total citations
19 papers, 562 citations indexed

About

Nicholas Beazley‐Long is a scholar working on Molecular Biology, Physiology and Ophthalmology. According to data from OpenAlex, Nicholas Beazley‐Long has authored 19 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Ophthalmology. Recurrent topics in Nicholas Beazley‐Long's work include Pain Mechanisms and Treatments (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Retinal Diseases and Treatments (4 papers). Nicholas Beazley‐Long is often cited by papers focused on Pain Mechanisms and Treatments (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Retinal Diseases and Treatments (4 papers). Nicholas Beazley‐Long collaborates with scholars based in United Kingdom, Switzerland and Japan. Nicholas Beazley‐Long's co-authors include Lucy F. Donaldson, David O. Bates, Richard P. Hulse, Steven J. Harper, Jing Hua, Heather S. Bevan, A Churchill, Nikita Ved, Andrew V. Benest and Melissa V. Gammons and has published in prestigious journals such as The Journal of Physiology, The FASEB Journal and Journal of Cell Science.

In The Last Decade

Nicholas Beazley‐Long

17 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Beazley‐Long United Kingdom 12 286 152 99 80 67 19 562
Priya Umapathi United States 11 566 2.0× 109 0.7× 53 0.5× 84 1.1× 79 1.2× 19 966
Yiqun Geng China 11 192 0.7× 113 0.7× 44 0.4× 42 0.5× 19 0.3× 38 470
Hideyuki Migita Japan 10 257 0.9× 51 0.3× 42 0.4× 50 0.6× 42 0.6× 11 487
Nathalie Lebeurrier France 8 212 0.7× 138 0.9× 97 1.0× 69 0.9× 22 0.3× 9 583
Raji Rajesh Lenin India 13 258 0.9× 69 0.5× 58 0.6× 21 0.3× 90 1.3× 24 510
Liu Yang China 15 237 0.8× 69 0.5× 49 0.5× 41 0.5× 237 3.5× 53 660
Annett Spudich Switzerland 6 258 0.9× 53 0.3× 39 0.4× 61 0.8× 68 1.0× 7 524
Megumu Tanaka Japan 15 213 0.7× 49 0.3× 31 0.3× 212 2.6× 42 0.6× 27 454
Xing Ji China 16 317 1.1× 64 0.4× 62 0.6× 24 0.3× 22 0.3× 45 654

Countries citing papers authored by Nicholas Beazley‐Long

Since Specialization
Citations

This map shows the geographic impact of Nicholas Beazley‐Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Beazley‐Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Beazley‐Long more than expected).

Fields of papers citing papers by Nicholas Beazley‐Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Beazley‐Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Beazley‐Long. The network helps show where Nicholas Beazley‐Long may publish in the future.

Co-authorship network of co-authors of Nicholas Beazley‐Long

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Beazley‐Long. A scholar is included among the top collaborators of Nicholas Beazley‐Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Beazley‐Long. Nicholas Beazley‐Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Beazley‐Long, Nicholas, et al.. (2022). Simple Gene Knockdown in Endothelial Cells Using Short Interfering RNA Oligonucleotides. Methods in molecular biology. 2441. 251–255. 1 indexed citations
2.
Beazley‐Long, Nicholas, et al.. (2022). Quantification of Angiogenesis in Laser Choroidal Neovascularization. Methods in molecular biology. 2441. 223–231. 2 indexed citations
3.
Aday, Sezin, Inbal Hazan‐Halevy, Aránzazu Chamorro-Jorganes, et al.. (2021). Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo. Molecular Therapy. 29(7). 2239–2252. 57 indexed citations
4.
Chamorro-Jorganes, Aránzazu, Rajesh Katare, Marie Besnier, et al.. (2021). METTL3 Regulates Angiogenesis by Modulating let-7e-5p and miRNA-18a-5p Expression in Endothelial Cells. Arteriosclerosis Thrombosis and Vascular Biology. 41(6). e325–e337. 47 indexed citations
5.
Beazley‐Long, Nicholas, et al.. (2020). AB0064 CHANGES IN THE VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGFA) SPLICING AXIS IN HUMAN SYNOVIUM ARE RELATED TO INFLAMMATION IN ARTHRITIS. Annals of the Rheumatic Diseases. 79. 1333–1334. 8 indexed citations
6.
Beazley‐Long, Nicholas. (2018). Do neuronal microvascular activation and resultant dysfunction in rheumatoid arthritis contribute to chronic pain?. Neural Regeneration Research. 14(1). 79–79. 1 indexed citations
7.
Beazley‐Long, Nicholas, Daryl Hodge, Andrew V. Benest, et al.. (2018). VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis. Brain Behavior and Immunity. 74. 49–67. 29 indexed citations
8.
Bates, David O., Nicholas Beazley‐Long, Andrew V. Benest, et al.. (2018). Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Comprehensive physiology. 8(3). 955–979. 24 indexed citations
9.
Bates, David O., Nicholas Beazley‐Long, Andrew V. Benest, et al.. (2018). Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Comprehensive physiology. 8(3). 955–979.
10.
Hulse, Richard P., Matthew Swift, Nikita Ved, et al.. (2018). Sensory neuronal sensitisation occurs through HMGB-1–RAGE and TRPV1 in high-glucose conditions. Journal of Cell Science. 131(14). 42 indexed citations
11.
Beazley‐Long, Nicholas, et al.. (2018). A role for pericytes in chronic pain?. Current Opinion in Supportive and Palliative Care. 12(2). 154–161.
12.
Ved, Nikita, Nicholas Beazley‐Long, Kurt Ballmer‐Hofer, et al.. (2018). Diabetes‐induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain. The Journal of Physiology. 596(16). 3675–3693. 28 indexed citations
13.
Donaldson, Lucy F. & Nicholas Beazley‐Long. (2016). Alternative RNA splicing: contribution to pain and potential therapeutic strategy. Drug Discovery Today. 21(11). 1787–1798. 33 indexed citations
14.
Hulse, Richard P., Nicholas Beazley‐Long, Nikita Ved, et al.. (2015). Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration. Clinical Science. 129(8). 741–756. 51 indexed citations
15.
Beazley‐Long, Nicholas, Kevin Gaston, Steven J. Harper, Antonio Orlando, & David O. Bates. (2015). Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression.. PubMed. 5(1). 433–41. 11 indexed citations
16.
Hulse, Richard P., Nicholas Beazley‐Long, Jing Hua, et al.. (2014). Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. Neurobiology of Disease. 71. 245–259. 63 indexed citations
17.
Beazley‐Long, Nicholas, Jing Hua, Thomas Jehle, et al.. (2013). VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro. American Journal Of Pathology. 183(3). 918–929. 91 indexed citations
18.
Beazley‐Long, Nicholas, et al.. (2010). VEGF‐A 165 b is cytoprotective for ARPE‐19 cells indicating a potential role in AMD therapy. The FASEB Journal. 24(S1). 1 indexed citations
19.
Magnussen, Anette, Emma Rennel, Jing Hua, et al.. (2010). VEGF-A165b Is Cytoprotective and Antiangiogenic in the Retina. Investigative Ophthalmology & Visual Science. 51(8). 4273–4273. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026